- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Addressing Pay-for-Delay Deals, Anticompetition in the Pharmaceutical Industry
Despite executive orders by the Biden administration aimed to improve competition in the pharmaceutical industry, pay-for-delay deals and other antitrust issues continue to be reported. On this episode of Managed Care Cast, we speak on the history and prevalence of these anticompetitive tactics and steps to limit these deals.
In the past year, executive orders by the Biden administration have aimed to improve competition in the pharmaceutical industry by addressing pay-for-delay deals that work to prevent generics from entering the market. Although a step in the right direction, anticompetitive deals continue to be reported as the Federal Trade Commission weighs how to properly penalize involved drug companies.
On this episode of Managed Care Cast, we speak with Michael Abrams, managing partner at Numerof & Associates, on persistent barriers to entry for generics entering the pharmaceutical market, the impact of antitrust laws issued by the Biden administration, and further steps that are warranted to address anticompetitive tactics.
Listen above or through one of these podcast services:
Patient Care Experience Declines After Private Equity Hospital Acquisitions
January 31st 2025Private equity hospital acquisitions in the US were associated with declines in patient care experience, particularly in overall hospital ratings, willingness to recommend, and staff responsiveness.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
